Cargando…
Correction: Štorkánová et al. Inhibition of Hsp90 Counteracts the Established Experimental Dermal Fibrosis Induced by Bleomycin. Biomedicines 2021, 9, 650
Autores principales: | Štorkánová, Hana, Štorkánová, Lenka, Navrátilová, Adéla, Bečvář, Viktor, Hulejová, Hana, Oreská, Sabína, Heřmánková, Barbora, Špiritović, Maja, Bečvář, Radim, Pavelka, Karel, Vencovský, Jiří, Distler, Jörg H. W., Šenolt, Ladislav, Tomčík, Michal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604650/ https://www.ncbi.nlm.nih.gov/pubmed/37893244 http://dx.doi.org/10.3390/biomedicines11102736 |
Ejemplares similares
-
Inhibition of Hsp90 Counteracts the Established Experimental Dermal Fibrosis Induced by Bleomycin
por: Štorkánová, Hana, et al.
Publicado: (2021) -
Effect of an 8-Week Tailored Physiotherapy Program on Sexual Health in Women with Scleroderma and Myositis: A Controlled Pilot Study
por: Heřmánková, Barbora, et al.
Publicado: (2023) -
Female Sexual Dysfunction and Pelvic Floor Muscle Function Associated with Systemic Sclerosis: A Cross-Sectional Study
por: Heřmánková, Barbora, et al.
Publicado: (2022) -
Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study
por: Štorkánová, Hana, et al.
Publicado: (2021) -
Sexual function in patients with idiopathic inflammatory myopathies: a cross-sectional study
por: Heřmánková, Barbora, et al.
Publicado: (2021)